Westover Capital Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.95M Buy
91,034
+2,025
+2% +$98.6K 0.82% 34
2026
Q1
$3.82M Buy
89,009
+2,582
+3% +$111K 0.7% 37
2025
Q4
$3.79M Buy
86,427
+9,392
+12% +$389K 0.69% 36
2025
Q3
$3.18M Buy
77,035
+29,316
+61% +$1.18M 0.59% 41
2025
Q2
$2.1M Buy
47,719
+6,336
+15% +$253K 0.42% 54
2025
Q1
$1.53M Buy
+41,383
New +$1.47M 0.34% 68
2019
Q3
Sell
-10,720
Closed -$229K 137
2019
Q2
$229K Sell
10,720
-15,883
-60% -$333K 0.11% 125
2019
Q1
$633K Buy
26,603
+14,450
+119% +$330K 0.33% 66
2018
Q4
$239K Buy
+12,153
New +$217K 0.15% 96

Other funds holding EXEL

Westover Capital Advisors's EXEL Position: Q2 2026 in Review

Westover Capital Advisors increased its Exelixis (EXEL) stake by 2.3% in Q2 2026, buying an estimated $98.6K and bringing the position to 91,034 shares worth $4.95M. The position accounts for 0.82% of the portfolio, ranked #34.

Westover Capital Advisors first reported a position in EXEL in Q4 2018 and has held it in 9 quarters since. 756 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Westover Capital Advisors held 91,034 shares of Exelixis worth $4.95M as of Q2 2026.
  • Westover Capital Advisors bought 2,025 Exelixis shares in Q2 2026, an estimated $98.6K.
  • Exelixis made up 0.82% of Westover Capital Advisors's portfolio in Q2 2026, its #34 holding.
  • Westover Capital Advisors first reported a position in Exelixis in Q4 2018 and has held it in 9 quarters since.
  • 756 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Westover Capital Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.